Female Hypoactive Sexual Desire Disorder Therapeutics Market Forecast to 2028 - COVID-19 Impact and Global Analysis by Therapy (Testosterone, Flibanserin, Buspirone, Bupropion, Bremelanotide, Cognitive Behavior Therapy); Application (In-patient, Out-patient)

Report Code: TIPRE00010487 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming

Covid
Assesing the covid-19 impact?
Get the Latest COVID-19 Analysis on this market
Request Now
Happy to join you in your fight against the COVID-19 economic pandemic!
MARKET INTRODUCTION

Hypoactive sexual desire disorder (HSDD) is sexual dysfunction. It is defined as a lack or absence of sexual fantasies and desire for sexual activity. It causes marked distress not be better accounted for by another mental disorder, a drug (legal or illegal), or some other medical condition. A person with HSDD will not start or respond to their partner's desire for sexual activity.

MARKET DYNAMICS

The female hypoactive sexual desire disorder therapeutics market is anticipated to grow due to increasing incidences and awareness of hypoactive sexual desire disorder. Moreover, changing lifestyle, and increasing technological advancements in the medical devices industry is expected to boost the growth of the market in the forecast period.

MARKET SCOPE

The "Female Hypoactive Sexual Desire Disorder Therapeutics Market Analysis to 2028" is a specialized and in-depth study of the pharmaceutical industry with a special focus on the global market trend analysis. The report aims to provide an overview of in female hypoactive sexual desire disorder therapeutics market with detailed market segmentation by therapy and application. The female hypoactive sexual desire disorder therapeutics market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading in female hypoactive sexual desire disorder therapeutics market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The female hypoactive sexual desire disorder therapeutics market is segmented on the basis of therapy and application. Based on therapy the market is segmented as testosterone, flibanserin, buspirone, bupropion, bremelanotide, and cognitive behavior therapy. On the basis of application the market is categorized as in-patient, and out-patient.

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the in female hypoactive sexual desire disorder therapeutics market based on various segments. It also provides market size and forecast estimates from year 2020 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The female hypoactive sexual desire disorder therapeutics market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting female hypoactive sexual desire disorder therapeutics market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the female hypoactive sexual desire disorder therapeutics market in these regions.



Get more information on this report :

MARKET PLAYERS


The report covers key developments in the in female hypoactive sexual desire disorder therapeutics market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from in female hypoactive sexual desire disorder therapeutics market are anticipated to have lucrative growth opportunities in the future with the rising demand for in female hypoactive sexual desire disorder therapeutics market in the global market. Below mentioned is the list of few companies engaged in the female hypoactive sexual desire disorder therapeutics market.

The report also includes the profiles of key in female hypoactive sexual desire disorder therapeutics market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.


  •   Allergan plc
  •   AMAG Pharmaceuticals, Inc.
  •   Emotional Brain BV
  •   Endoceutics, Inc.
  •   GlaxoSmithKline Plc
  •   Merck & Co., Inc.
  •   Palatin Technologies Inc
  •   Pivot Pharmaceuticals Inc
  •   Sprout Pharmaceuticals, Inc.
  •   Strategic Science & Technologies, LLC


The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.


Get more information on this report :

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Female Hypoactive Sexual Desire Disorder Therapeutics Market - By Therapy
1.3.2 Female Hypoactive Sexual Desire Disorder Therapeutics Market - By Application
1.3.3 Female Hypoactive Sexual Desire Disorder Therapeutics Market - By Region
1.3.3.1 By Country

2. KEY TAKEAWAYS

3. RESEARCH METHODOLOGY

4. FEMALE HYPOACTIVE SEXUAL DESIRE DISORDER THERAPEUTICS MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS

5. FEMALE HYPOACTIVE SEXUAL DESIRE DISORDER THERAPEUTICS MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. FEMALE HYPOACTIVE SEXUAL DESIRE DISORDER THERAPEUTICS MARKET - GLOBAL MARKET ANALYSIS
6.1. FEMALE HYPOACTIVE SEXUAL DESIRE DISORDER THERAPEUTICS - GLOBAL MARKET OVERVIEW
6.2. FEMALE HYPOACTIVE SEXUAL DESIRE DISORDER THERAPEUTICS - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING/MARKET SHARE
7. FEMALE HYPOACTIVE SEXUAL DESIRE DISORDER THERAPEUTICS MARKET - REVENUE AND FORECASTS TO 2028 - THERAPY
7.1. OVERVIEW
7.2. THERAPY MARKET FORECASTS AND ANALYSIS
7.3. TESTOSTERONE
7.3.1. Overview
7.3.2. Testosterone Market Forecast and Analysis
7.4. FLIBANSERIN
7.4.1. Overview
7.4.2. Flibanserin Market Forecast and Analysis
7.5. BUSPIRONE
7.5.1. Overview
7.5.2. Buspirone Market Forecast and Analysis
7.6. BUPROPION
7.6.1. Overview
7.6.2. Bupropion Market Forecast and Analysis
7.7. BREMELANOTIDE
7.7.1. Overview
7.7.2. Bremelanotide Market Forecast and Analysis
7.8. COGNITIVE BEHAVIOR THERAPY
7.8.1. Overview
7.8.2. Cognitive Behavior Therapy Market Forecast and Analysis
8. FEMALE HYPOACTIVE SEXUAL DESIRE DISORDER THERAPEUTICS MARKET - REVENUE AND FORECASTS TO 2028 - APPLICATION
8.1. OVERVIEW
8.2. APPLICATION MARKET FORECASTS AND ANALYSIS
8.3. IN-PATIENT
8.3.1. Overview
8.3.2. In-patient Market Forecast and Analysis
8.4. OUT-PATIENT
8.4.1. Overview
8.4.2. Out-patient Market Forecast and Analysis
9. FEMALE HYPOACTIVE SEXUAL DESIRE DISORDER THERAPEUTICS MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Female Hypoactive Sexual Desire Disorder Therapeutics Market Overview
9.1.2 North America Female Hypoactive Sexual Desire Disorder Therapeutics Market Forecasts and Analysis
9.1.3 North America Female Hypoactive Sexual Desire Disorder Therapeutics Market Forecasts and Analysis - By Therapy
9.1.4 North America Female Hypoactive Sexual Desire Disorder Therapeutics Market Forecasts and Analysis - By Application
9.1.5 North America Female Hypoactive Sexual Desire Disorder Therapeutics Market Forecasts and Analysis - By Countries
9.1.5.1 United States Female Hypoactive Sexual Desire Disorder Therapeutics Market
9.1.5.1.1 United States Female Hypoactive Sexual Desire Disorder Therapeutics Market by Therapy
9.1.5.1.2 United States Female Hypoactive Sexual Desire Disorder Therapeutics Market by Application
9.1.5.2 Canada Female Hypoactive Sexual Desire Disorder Therapeutics Market
9.1.5.2.1 Canada Female Hypoactive Sexual Desire Disorder Therapeutics Market by Therapy
9.1.5.2.2 Canada Female Hypoactive Sexual Desire Disorder Therapeutics Market by Application
9.1.5.3 Mexico Female Hypoactive Sexual Desire Disorder Therapeutics Market
9.1.5.3.1 Mexico Female Hypoactive Sexual Desire Disorder Therapeutics Market by Therapy
9.1.5.3.2 Mexico Female Hypoactive Sexual Desire Disorder Therapeutics Market by Application
9.2. EUROPE
9.2.1 Europe Female Hypoactive Sexual Desire Disorder Therapeutics Market Overview
9.2.2 Europe Female Hypoactive Sexual Desire Disorder Therapeutics Market Forecasts and Analysis
9.2.3 Europe Female Hypoactive Sexual Desire Disorder Therapeutics Market Forecasts and Analysis - By Therapy
9.2.4 Europe Female Hypoactive Sexual Desire Disorder Therapeutics Market Forecasts and Analysis - By Application
9.2.5 Europe Female Hypoactive Sexual Desire Disorder Therapeutics Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Female Hypoactive Sexual Desire Disorder Therapeutics Market
9.2.5.1.1 Germany Female Hypoactive Sexual Desire Disorder Therapeutics Market by Therapy
9.2.5.1.2 Germany Female Hypoactive Sexual Desire Disorder Therapeutics Market by Application
9.2.5.2 France Female Hypoactive Sexual Desire Disorder Therapeutics Market
9.2.5.2.1 France Female Hypoactive Sexual Desire Disorder Therapeutics Market by Therapy
9.2.5.2.2 France Female Hypoactive Sexual Desire Disorder Therapeutics Market by Application
9.2.5.3 Italy Female Hypoactive Sexual Desire Disorder Therapeutics Market
9.2.5.3.1 Italy Female Hypoactive Sexual Desire Disorder Therapeutics Market by Therapy
9.2.5.3.2 Italy Female Hypoactive Sexual Desire Disorder Therapeutics Market by Application
9.2.5.4 Spain Female Hypoactive Sexual Desire Disorder Therapeutics Market
9.2.5.4.1 Spain Female Hypoactive Sexual Desire Disorder Therapeutics Market by Therapy
9.2.5.4.2 Spain Female Hypoactive Sexual Desire Disorder Therapeutics Market by Application
9.2.5.5 United Kingdom Female Hypoactive Sexual Desire Disorder Therapeutics Market
9.2.5.5.1 United Kingdom Female Hypoactive Sexual Desire Disorder Therapeutics Market by Therapy
9.2.5.5.2 United Kingdom Female Hypoactive Sexual Desire Disorder Therapeutics Market by Application
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Female Hypoactive Sexual Desire Disorder Therapeutics Market Overview
9.3.2 Asia-Pacific Female Hypoactive Sexual Desire Disorder Therapeutics Market Forecasts and Analysis
9.3.3 Asia-Pacific Female Hypoactive Sexual Desire Disorder Therapeutics Market Forecasts and Analysis - By Therapy
9.3.4 Asia-Pacific Female Hypoactive Sexual Desire Disorder Therapeutics Market Forecasts and Analysis - By Application
9.3.5 Asia-Pacific Female Hypoactive Sexual Desire Disorder Therapeutics Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Female Hypoactive Sexual Desire Disorder Therapeutics Market
9.3.5.1.1 Australia Female Hypoactive Sexual Desire Disorder Therapeutics Market by Therapy
9.3.5.1.2 Australia Female Hypoactive Sexual Desire Disorder Therapeutics Market by Application
9.3.5.2 China Female Hypoactive Sexual Desire Disorder Therapeutics Market
9.3.5.2.1 China Female Hypoactive Sexual Desire Disorder Therapeutics Market by Therapy
9.3.5.2.2 China Female Hypoactive Sexual Desire Disorder Therapeutics Market by Application
9.3.5.3 India Female Hypoactive Sexual Desire Disorder Therapeutics Market
9.3.5.3.1 India Female Hypoactive Sexual Desire Disorder Therapeutics Market by Therapy
9.3.5.3.2 India Female Hypoactive Sexual Desire Disorder Therapeutics Market by Application
9.3.5.4 Japan Female Hypoactive Sexual Desire Disorder Therapeutics Market
9.3.5.4.1 Japan Female Hypoactive Sexual Desire Disorder Therapeutics Market by Therapy
9.3.5.4.2 Japan Female Hypoactive Sexual Desire Disorder Therapeutics Market by Application
9.3.5.5 South Korea Female Hypoactive Sexual Desire Disorder Therapeutics Market
9.3.5.5.1 South Korea Female Hypoactive Sexual Desire Disorder Therapeutics Market by Therapy
9.3.5.5.2 South Korea Female Hypoactive Sexual Desire Disorder Therapeutics Market by Application
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Female Hypoactive Sexual Desire Disorder Therapeutics Market Overview
9.4.2 Middle East and Africa Female Hypoactive Sexual Desire Disorder Therapeutics Market Forecasts and Analysis
9.4.3 Middle East and Africa Female Hypoactive Sexual Desire Disorder Therapeutics Market Forecasts and Analysis - By Therapy
9.4.4 Middle East and Africa Female Hypoactive Sexual Desire Disorder Therapeutics Market Forecasts and Analysis - By Application
9.4.5 Middle East and Africa Female Hypoactive Sexual Desire Disorder Therapeutics Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Female Hypoactive Sexual Desire Disorder Therapeutics Market
9.4.5.1.1 South Africa Female Hypoactive Sexual Desire Disorder Therapeutics Market by Therapy
9.4.5.1.2 South Africa Female Hypoactive Sexual Desire Disorder Therapeutics Market by Application
9.4.5.2 Saudi Arabia Female Hypoactive Sexual Desire Disorder Therapeutics Market
9.4.5.2.1 Saudi Arabia Female Hypoactive Sexual Desire Disorder Therapeutics Market by Therapy
9.4.5.2.2 Saudi Arabia Female Hypoactive Sexual Desire Disorder Therapeutics Market by Application
9.4.5.3 U.A.E Female Hypoactive Sexual Desire Disorder Therapeutics Market
9.4.5.3.1 U.A.E Female Hypoactive Sexual Desire Disorder Therapeutics Market by Therapy
9.4.5.3.2 U.A.E Female Hypoactive Sexual Desire Disorder Therapeutics Market by Application
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Female Hypoactive Sexual Desire Disorder Therapeutics Market Overview
9.5.2 South and Central America Female Hypoactive Sexual Desire Disorder Therapeutics Market Forecasts and Analysis
9.5.3 South and Central America Female Hypoactive Sexual Desire Disorder Therapeutics Market Forecasts and Analysis - By Therapy
9.5.4 South and Central America Female Hypoactive Sexual Desire Disorder Therapeutics Market Forecasts and Analysis - By Application
9.5.5 South and Central America Female Hypoactive Sexual Desire Disorder Therapeutics Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Female Hypoactive Sexual Desire Disorder Therapeutics Market
9.5.5.1.1 Brazil Female Hypoactive Sexual Desire Disorder Therapeutics Market by Therapy
9.5.5.1.2 Brazil Female Hypoactive Sexual Desire Disorder Therapeutics Market by Application
9.5.5.2 Argentina Female Hypoactive Sexual Desire Disorder Therapeutics Market
9.5.5.2.1 Argentina Female Hypoactive Sexual Desire Disorder Therapeutics Market by Therapy
9.5.5.2.2 Argentina Female Hypoactive Sexual Desire Disorder Therapeutics Market by Application
10. INDUSTRY LANDSCAPE
10.1. MERGERS AND ACQUISITIONS
10.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
10.3. NEW PRODUCT LAUNCHES
10.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
11. FEMALE HYPOACTIVE SEXUAL DESIRE DISORDER THERAPEUTICS MARKET, KEY COMPANY PROFILES
11.1. ALLERGAN PLC
11.1.1. Key Facts
11.1.2. Business Description
11.1.3. Products and Services
11.1.4. Financial Overview
11.1.5. SWOT Analysis
11.1.6. Key Developments
11.2. AMAG PHARMACEUTICALS, INC.
11.2.1. Key Facts
11.2.2. Business Description
11.2.3. Products and Services
11.2.4. Financial Overview
11.2.5. SWOT Analysis
11.2.6. Key Developments
11.3. EMOTIONAL BRAIN BV
11.3.1. Key Facts
11.3.2. Business Description
11.3.3. Products and Services
11.3.4. Financial Overview
11.3.5. SWOT Analysis
11.3.6. Key Developments
11.4. ENDOCEUTICS, INC.
11.4.1. Key Facts
11.4.2. Business Description
11.4.3. Products and Services
11.4.4. Financial Overview
11.4.5. SWOT Analysis
11.4.6. Key Developments
11.5. GLAXOSMITHKLINE PLC
11.5.1. Key Facts
11.5.2. Business Description
11.5.3. Products and Services
11.5.4. Financial Overview
11.5.5. SWOT Analysis
11.5.6. Key Developments
11.6. MERCK AND CO., INC.
11.6.1. Key Facts
11.6.2. Business Description
11.6.3. Products and Services
11.6.4. Financial Overview
11.6.5. SWOT Analysis
11.6.6. Key Developments
11.7. PALATIN TECHNOLOGIES INC
11.7.1. Key Facts
11.7.2. Business Description
11.7.3. Products and Services
11.7.4. Financial Overview
11.7.5. SWOT Analysis
11.7.6. Key Developments
11.8. PIVOT PHARMACEUTICALS INC
11.8.1. Key Facts
11.8.2. Business Description
11.8.3. Products and Services
11.8.4. Financial Overview
11.8.5. SWOT Analysis
11.8.6. Key Developments
11.9. SPROUT PHARMACEUTICALS, INC.
11.9.1. Key Facts
11.9.2. Business Description
11.9.3. Products and Services
11.9.4. Financial Overview
11.9.5. SWOT Analysis
11.9.6. Key Developments
11.10. STRATEGIC SCIENCE AND TECHNOLOGIES, LLC
11.10.1. Key Facts
11.10.2. Business Description
11.10.3. Products and Services
11.10.4. Financial Overview
11.10.5. SWOT Analysis
11.10.6. Key Developments
12. APPENDIX
12.1. ABOUT THE INSIGHT PARTNERS
12.2. GLOSSARY OF TERMS
The List of Companies

1. Allergan plc
2. AMAG Pharmaceuticals, Inc.
3. Emotional Brain BV
4. Endoceutics, Inc.
5. GlaxoSmithKline Plc
6. Merck & Co., Inc.
7. Palatin Technologies Inc
8. Pivot Pharmaceuticals Inc
9. Sprout Pharmaceuticals, Inc.
10. Strategic Science & Technologies, LLC
TIPRE00010487
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing

Free

20%

customization on Pre-Booking